These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 32526245)

  • 21. Impaired autophagy in microglia aggravates dopaminergic neurodegeneration by regulating NLRP3 inflammasome activation in experimental models of Parkinson's disease.
    Qin Y; Qiu J; Wang P; Liu J; Zhao Y; Jiang F; Lou H
    Brain Behav Immun; 2021 Jan; 91():324-338. PubMed ID: 33039664
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long noncoding RNA GAS5 promotes microglial inflammatory response in Parkinson's disease by regulating NLRP3 pathway through sponging miR-223-3p.
    Xu W; Zhang L; Geng Y; Liu Y; Zhang N
    Int Immunopharmacol; 2020 Aug; 85():106614. PubMed ID: 32470877
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Asiaticoside exerts neuroprotection through targeting NLRP3 inflammasome activation.
    He Z; Hu Y; Zhang Y; Xie J; Niu Z; Yang G; Zhang J; Zhao Z; Wei S; Wu H; Hu W
    Phytomedicine; 2024 May; 127():155494. PubMed ID: 38471370
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treadmill exercise alleviates neuronal damage by suppressing NLRP3 inflammasome and microglial activation in the MPTP mouse model of Parkinson's disease.
    Wang W; Lv Z; Gao J; Liu M; Wang Y; Tang C; Xiang J
    Brain Res Bull; 2021 Sep; 174():349-358. PubMed ID: 34224819
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Baicalin exerts neuroprotective actions by regulating the Nrf2-NLRP3 axis in toxin-induced models of Parkinson's disease.
    Huang J; Zhang X; Yang X; Yv Q; Ye F; Chen S; Cui Y; Gu L; Zhu M; Li W
    Chem Biol Interact; 2024 Jan; 387():110820. PubMed ID: 38016618
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Urolithin A promotes mitophagy and suppresses NLRP3 inflammasome activation in lipopolysaccharide-induced BV2 microglial cells and MPTP-induced Parkinson's disease model.
    Qiu J; Chen Y; Zhuo J; Zhang L; Liu J; Wang B; Sun D; Yu S; Lou H
    Neuropharmacology; 2022 Apr; 207():108963. PubMed ID: 35065082
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Distinct Nrf2 Signaling Mechanisms of Fumaric Acid Esters and Their Role in Neuroprotection against 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Induced Experimental Parkinson's-Like Disease.
    Ahuja M; Ammal Kaidery N; Yang L; Calingasan N; Smirnova N; Gaisin A; Gaisina IN; Gazaryan I; Hushpulian DM; Kaddour-Djebbar I; Bollag WB; Morgan JC; Ratan RR; Starkov AA; Beal MF; Thomas B
    J Neurosci; 2016 Jun; 36(23):6332-51. PubMed ID: 27277809
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safranal exerts a neuroprotective effect on Parkinson's disease with suppression of NLRP3 inflammation activation.
    Yang W; Wei Y; Sun J; Yao C; Ai F; Ding H
    Mol Biol Rep; 2024 Apr; 51(1):593. PubMed ID: 38683404
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuroprotective effects of human umbilical cord mesenchymal stromal cells in PD mice via centrally and peripherally suppressing NLRP3 inflammasome-mediated inflammatory responses.
    Zhou L; Wang X; Wang X; An J; Zheng X; Han D; Chen Z
    Biomed Pharmacother; 2022 Sep; 153():113535. PubMed ID: 36076517
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tenuigenin protects dopaminergic neurons from inflammation via suppressing NLRP3 inflammasome activation in microglia.
    Fan Z; Liang Z; Yang H; Pan Y; Zheng Y; Wang X
    J Neuroinflammation; 2017 Dec; 14(1):256. PubMed ID: 29262843
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA-30e regulates neuroinflammation in MPTP model of Parkinson's disease by targeting Nlrp3.
    Li D; Yang H; Ma J; Luo S; Chen S; Gu Q
    Hum Cell; 2018 Apr; 31(2):106-115. PubMed ID: 29274035
    [TBL] [Abstract][Full Text] [Related]  

  • 32. p38-TFEB pathways promote microglia activation through inhibiting CMA-mediated NLRP3 degradation in Parkinson's disease.
    Chen J; Mao K; Yu H; Wen Y; She H; Zhang H; Liu L; Li M; Li W; Zou F
    J Neuroinflammation; 2021 Dec; 18(1):295. PubMed ID: 34930303
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of the hepatic Nlrp3 protects dopaminergic neurons via attenuating systemic inflammation in a MPTP/p mouse model of Parkinson's disease.
    Qiao C; Zhang Q; Jiang Q; Zhang T; Chen M; Fan Y; Ding J; Lu M; Hu G
    J Neuroinflammation; 2018 Jul; 15(1):193. PubMed ID: 29966531
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sodium Butyrate Exacerbates Parkinson's Disease by Aggravating Neuroinflammation and Colonic Inflammation in MPTP-Induced Mice Model.
    Qiao CM; Sun MF; Jia XB; Li Y; Zhang BP; Zhao LP; Shi Y; Zhou ZL; Zhu YL; Cui C; Shen YQ
    Neurochem Res; 2020 Sep; 45(9):2128-2142. PubMed ID: 32556930
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Understanding the involvement of innate immunity and the Nrf2-NLRP3 axis on mitochondrial health in Parkinson's disease.
    Rajan S; Tryphena KP; Khan S; Vora L; Srivastava S; Singh SB; Khatri DK
    Ageing Res Rev; 2023 Jun; 87():101915. PubMed ID: 36963313
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of long non-coding RNA HOXA11-AS against neuroinflammation in Parkinson's disease model via targeting miR-124-3p mediated FSTL1/NF-κB axis.
    Cao H; Han X; Jia Y; Zhang B
    Aging (Albany NY); 2021 Apr; 13(8):11455-11469. PubMed ID: 33839699
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Parkin regulates microglial NLRP3 and represses neurodegeneration in Parkinson's disease.
    Yan YQ; Zheng R; Liu Y; Ruan Y; Lin ZH; Xue NJ; Chen Y; Zhang BR; Pu JL
    Aging Cell; 2023 Jun; 22(6):e13834. PubMed ID: 37029500
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Small molecule-driven NLRP3 inflammation inhibition via interplay between ubiquitination and autophagy: implications for Parkinson disease.
    Han X; Sun S; Sun Y; Song Q; Zhu J; Song N; Chen M; Sun T; Xia M; Ding J; Lu M; Yao H; Hu G
    Autophagy; 2019 Nov; 15(11):1860-1881. PubMed ID: 30966861
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Melatonin Attenuates Neuroinflammation by Down-Regulating NLRP3 Inflammasome via a SIRT1-Dependent Pathway in MPTP-Induced Models of Parkinson's Disease.
    Zheng R; Ruan Y; Yan Y; Lin Z; Xue N; Yan Y; Tian J; Yin X; Pu J; Zhang B
    J Inflamm Res; 2021; 14():3063-3075. PubMed ID: 34267535
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TLR4 deficiency has a protective effect in the MPTP/probenecid mouse model of Parkinson's disease.
    Shao QH; Chen Y; Li FF; Wang S; Zhang XL; Yuan YH; Chen NH
    Acta Pharmacol Sin; 2019 Dec; 40(12):1503-1512. PubMed ID: 31388087
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.